Showing 461 - 480 results of 224,563 for search '(( end point decrease ) OR ( 10 ((teer decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.41s Refine Results
  1. 461

    Long-term treatment with rapamycin results in decrease in progenitor cells. by Zhenya Lu (780517)

    Published 2015
    “…Quantitative calculation of DCX-positive cells per field in different groups. Rats treated with 1.0 and 3.0 mg/kg rapamycin demonstrated decrease in DCX-positive cells. …”
  2. 462
  3. 463
  4. 464
  5. 465
  6. 466
  7. 467
  8. 468

    Decreased Patrolling Efficiency and Decreased ConA Hepatitis Severity in CXCR6-Deficient Mice by Frederic Geissmann (75)

    Published 2013
    “…The density of GFP<sup>+</sup> cells in <i>cxcr6<sup>gfp/+</sup></i> and <i>cxcr6<sup>gfp/gfp</sup></i> mice (middle panel) was calculated from the intravital videos used in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0030113#pbio-0030113-g003" target="_blank">Figure 3</a> and the flow cytometry data in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0030113#pbio-0030113-g002" target="_blank">Figure 2</a>. …”
  9. 469

    Table_2_Transcutaneous Electrical Acupoint Stimulation Decreases the Incidence of Postoperative Nausea and Vomiting After Laparoscopic Non-gastrointestinal Surgery: A Multi-Center... by Wei Gao (2085)

    Published 2022
    “…</p>Main Outcomes and Measures<p>Primary clinical end point is the incidence of PONV which was defined as at least one incidence of nausea, retching, or vomiting after operation within postoperative 24 h.…”
  10. 470

    Table_1_Transcutaneous Electrical Acupoint Stimulation Decreases the Incidence of Postoperative Nausea and Vomiting After Laparoscopic Non-gastrointestinal Surgery: A Multi-Center... by Wei Gao (2085)

    Published 2022
    “…</p>Main Outcomes and Measures<p>Primary clinical end point is the incidence of PONV which was defined as at least one incidence of nausea, retching, or vomiting after operation within postoperative 24 h.…”
  11. 471
  12. 472
  13. 473
  14. 474
  15. 475
  16. 476
  17. 477

    Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

    Published 2011
    “…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”
  18. 478
  19. 479
  20. 480